Monitoring of myocardial injury by serial measurements of QRS area and T area: The MaastrICCht cohort.
electrocardiogram
intensive care monitoring
myocardial injury
serial
vectorcardiogram
Journal
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
revised:
03
05
2024
received:
03
07
2023
accepted:
14
07
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
4
9
2024
Statut:
ppublish
Résumé
Manually derived electrocardiographic (ECG) parameters were not associated with mortality in mechanically ventilated COVID-19 patients in earlier studies, while increased high-sensitivity cardiac troponin-T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were. To provide evidence for vectorcardiography (VCG) measures as potential cardiac monitoring tool, we investigated VCG trajectories during critical illness. All mechanically ventilated COVID-19 patients were included in the Maastricht Intensive Care Covid Cohort between March 2020 and October 2021. Serum hs-cTnT and NT-proBNP concentrations were measured daily. Conversion of daily 12-lead ECGs to VCGs by a MATLAB-based script provided QRS area, T area, maximal QRS amplitude, and QRS duration. Linear mixed-effect models investigated trajectories in serum and VCG markers over time between non-survivors and survivors, adjusted for confounders. In 322 patients, 5461 hs-cTnT, 5435 NT-proBNP concentrations and 3280 ECGs and VCGs were analyzed. Non-survivors had higher hs-cTnT concentrations at intubation and both hs-cTnT and NT-proBNP significantly increased compared with survivors. In non-survivors, the following VCG parameters decreased more when compared to survivors: QRS area (-0.27 (95% CI) (-0.37 to -0.16, p < .01) μVs per day), T area (-0.39 (-0.62 to -0.16, p < .01) μVs per day), and maximal QRS amplitude (-0.01 (-0.01 to -0.01, p < .01) mV per day). QRS duration did not differ. VCG-derived QRS area and T area decreased in non-survivors compared with survivors, suggesting that an increase in myocardial damage and tissue loss play a role in the course of critical illness and may drive mortality. These VCG markers may be used to monitor critically ill patients.
Sections du résumé
BACKGROUND
BACKGROUND
Manually derived electrocardiographic (ECG) parameters were not associated with mortality in mechanically ventilated COVID-19 patients in earlier studies, while increased high-sensitivity cardiac troponin-T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were. To provide evidence for vectorcardiography (VCG) measures as potential cardiac monitoring tool, we investigated VCG trajectories during critical illness.
METHODS
METHODS
All mechanically ventilated COVID-19 patients were included in the Maastricht Intensive Care Covid Cohort between March 2020 and October 2021. Serum hs-cTnT and NT-proBNP concentrations were measured daily. Conversion of daily 12-lead ECGs to VCGs by a MATLAB-based script provided QRS area, T area, maximal QRS amplitude, and QRS duration. Linear mixed-effect models investigated trajectories in serum and VCG markers over time between non-survivors and survivors, adjusted for confounders.
RESULTS
RESULTS
In 322 patients, 5461 hs-cTnT, 5435 NT-proBNP concentrations and 3280 ECGs and VCGs were analyzed. Non-survivors had higher hs-cTnT concentrations at intubation and both hs-cTnT and NT-proBNP significantly increased compared with survivors. In non-survivors, the following VCG parameters decreased more when compared to survivors: QRS area (-0.27 (95% CI) (-0.37 to -0.16, p < .01) μVs per day), T area (-0.39 (-0.62 to -0.16, p < .01) μVs per day), and maximal QRS amplitude (-0.01 (-0.01 to -0.01, p < .01) mV per day). QRS duration did not differ.
CONCLUSION
CONCLUSIONS
VCG-derived QRS area and T area decreased in non-survivors compared with survivors, suggesting that an increase in myocardial damage and tissue loss play a role in the course of critical illness and may drive mortality. These VCG markers may be used to monitor critically ill patients.
Substances chimiques
Peptide Fragments
0
Troponin T
0
pro-brain natriuretic peptide (1-76)
0
Natriuretic Peptide, Brain
114471-18-0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e70001Informations de copyright
© 2024 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Références
An, W., Kang, J.‐S., Wang, Q., & Kim, T.‐E. (2021). Cardiac biomarkers and COVID‐19: A systematic review and meta‐analysis. Journal of Infection and Public Health, 14(9), 1191–1197.
Angeli, F., Spanevello, A., De Ponti, R., Visca, D., Marazzato, J., Palmiotto, G., Feci, D., Reboldi, G., Fabbri, L. M., & Verdecchia, P. (2020). Electrocardiographic features of patients with COVID‐19 pneumonia. European Journal of Internal Medicine, 78, 101–106.
Bels, J. L. M., van Kuijk, S. M. J., Ghossein‐Doha, C., Tijssen, F. H., van Gassel, R. J. J., Tas, J., Collaborators, M. I. C. C., Schnabel, R. M., Aries, M. J. H., van de Poll, M. C. G., Bergmans, D. C. J. J., Meex, S. J. R., van Mook, W. N. K. A., van der Horst, I. C. C., & van Bussel, B. C. T. (2021). Decreased serial scores of severe organ failure assessments are associated with survival in mechanically ventilated patients; the prospective Maastricht Intensive Care COVID cohort. Journal of Critical Care, 62, 38–45.
Bergamaschi, L., D'Angelo, E. C., Paolisso, P., Toniolo, S., Fabrizio, M., Angeli, F., Donati, F., Magnani, I., Rinaldi, A., Bartoli, L., Chiti, C., Biffi, M., Pizzi, C., Viale, P., & Galié, N. (2021). The value of ECG changes in risk stratification of COVID‐19 patients. Annals of Noninvasive Electrocardiology, 26(3), e12815.
Dawson, D., Dominic, P., Sheth, A., & Modi, M. (2020). Prognostic value of cardiac biomarkers in COVID‐19 infection: A meta‐analysis. Research Square.
Emerek, K., Friedman, D. J., Sorensen, P. L., Hansen, S. M., Larsen, J. M., Risum, N., Thøgersen, A. M., Graff, C., Kisslo, J., Søgaard, P., & Atwater, B. D. (2019). Vectorcardiographic QRS area is associated with long‐term outcome after cardiac resynchronization therapy. Heart Rhythm, 16(2), 213–219.
Ghossein, M. A., Driessen, R. G. H., van Rosmalen, F., Sels, J. E. M., Delnoij, T., Geyik, Z., Mingels, A. M. A., van Stipdonk, A. M. W., Prinzen, F. W., Ghossein‐Doha, C., van Kuijk, S. M. J., van der Horst, I. C. C., Vernooy, K., & van Bussel, B. C. T. (2022). Serial assessment of myocardial injury markers in mechanically ventilated patients with SARS‐CoV‐2 (from the prospective MaastrICCht cohort). The American Journal of Cardiology, 170, 118–127.
Ghossein, M. A., van Stipdonk, A. M. W., Plesinger, F., Kloosterman, M., Wouters, P. C., Salden, O. A. E., Meine, M., Maass, A. H., Prinzen, F. W., & Vernooy, K. (2021). Reduction in the QRS area after cardiac resynchronization therapy is associated with survival and echocardiographic response. Journal of Cardiovascular Electrophysiology, 32(3), 813–822.
Goldberger, A. L., Bhargava, V., Froelicher, V., Covell, J., & Mortara, D. (1980). Effect of myocardial infarction on the peak amplitude of high frequency QRS potentials. Journal of Electrocardiology, 13(4), 367–371.
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storti, E., … Zoia, E. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS‐CoV‐2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574–1581.
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID‐19). JAMA Cardiology, 5(7), 811–818.
Habets, M. A. W., Sturkenboom, H. N., Tio, R. A., Belfroid, E., Hoogervorst‐Schilp, J., Siebelink, H. J., Jansen, C. W., & Smits, P. C. (2021). How often and to what extent do admitted COVID‐19 patients have signs of cardiac injury? Netherlands Heart Journal, 29(1), 5–12.
He, Y., Xie, M., Zhao, J., & Liu, X. (2020). Clinical characteristics and outcomes of patients with severe COVID‐19 and chronic obstructive pulmonary disease (COPD). Medical Science Monitor, 26, e927212.
Heines, S. J. H., van Bussel, B. C. T., Jong, M. J. A., Bennis, F. C., van Gassel, R. J. J., Groven, R. V. M., Heijnen, N. F. L., Hermans, B. J. M., Hounjet, R., van Koll, J., Mulder, M. M. G., van de Poll, M. C. G., van Rosmalen, F., Segers, R., Steyns, S., Strauch, U., Tas, J., van der Horst, I. C. C., van Kuijk, S. M. J., & Bergmans, D. C. J. J. (2022). Pulmonary pathophysiology development of COVID‐19 assessed by serial electrical impedance tomography in the MaastrICCht cohort. Scientific Reports, 12(1), 14517.
Hernández‐Garduño, E. (2020). Obesity is the comorbidity more strongly associated for Covid‐19 in Mexico. A case‐control study. Obesity Research & Clinical Practice, 14(4), 375–379.
Hulshof, A. M., Bruggemann, R. A. G., Mulder, M. M. G., van de Berg, T. W., Sels, J. E. M., Olie, R. H., Spaetgens, B., Streng, A. S., Verhezen, P., van der Horst, I. C. C., Ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Henskens, Y. M. C. (2021). Serial EXTEM, FIBTEM, and tPA rotational thromboelastometry observations in the Maastricht intensive care COVID cohort‐persistence of hypercoagulability and hypofibrinolysis despite anticoagulation. Frontiers in Cardiovascular Medicine, 8, 654174.
Kabutoya, T., Imai, Y., Yokoyama, Y., Yokota, A., Watanabe, T., Komori, T., & Kario, K. (2018). A larger vectorcardiographic QRS area is associated with left bundle branch block and good prognosis in patients with cardiac resynchronization therapy. Journal of Electrocardiology, 51(6), 1099–1102.
Kors, J. A., van Herpen, G., Sittig, A. C., & van Bemmel, J. H. (1990). Reconstruction of the Frank vectorcardiogram from standard electrocardiographic leads: Diagnostic comparison of different methods. European Heart Journal, 11(12), 1083–1092.
Marinko, S., Platonov, P. G., Carlson, J., & Borgquist, R. (2022). Baseline QRS area and reduction in QRS area are associated with lower mortality and risk of heart failure hospitalization after cardiac resynchronization therapy. Cardiology, 147(3), 298–306.
Martens, B., Driessen, R. G. H., Brandts, L., Hoitinga, P., van Veen, F., Driessen, M., Weberndörfer, V., Kietselaer, B., Ghossein‐Doha, C., Gietema, H. A., MaastrICCht Collaborators, Vernooy, K., van der Horst, I. C. C., Wildberger, J. E., van Bussel, B. C. T., & Mihl, C. (2022). Coronary artery calcifications are associated with more severe multiorgan failure in patients with severe coronavirus disease 2019 infection: Longitudinal results of the Maastricht Intensive Care COVID cohort. Journal of Thoracic Imaging, 37(4), 217–224.
Mulder, M. M. G., Brandts, L., Bruggemann, R. A. G., Koelmann, M., Streng, A. S., Olie, R. H., Gietema, H. A., Spronk, H. M. H., van der Horst, I. C. C., Sels, J. E. M., Wildberger, J. E., van Kuijk, S. M. J., Schnabel, R. M., Ten Cate, H., Henskens, Y. M. C., & van Bussel, B. C. T. (2021). Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS‐CoV‐2 infection; the prospective Maastricht intensive care COVID cohort. Thrombosis Journal, 19(1), 35.
Nguyen, U. C., Claridge, S., Vernooy, K., Engels, E. B., Razavi, R., Rinaldi, C. A., Chen, Z., & Prinzen, F. W. (2018). Relationship between vectorcardiographic QRSarea, myocardial scar quantification, and response to cardiac resynchronization therapy. Journal of Electrocardiology, 51(3), 457–463.
Okafor, O., Zegard, A., van Dam, P., Stegemann, B., Qiu, T., Marshall, H., & Leyva, F. (2019). Changes in QRS area and QRS duration after cardiac resynchronization therapy predict cardiac mortality, heart failure hospitalizations, and ventricular arrhythmias. Journal of the American Heart Association, 8(21), e013539.
R Core Team. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing.
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., Huang, H., Yang, B., & Huang, C. (2020). Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China. JAMA Cardiology, 5(7), 802–810.
Stefanini, G. G., Chiarito, M., Ferrante, G., Cannata, F., Azzolini, E., Viggiani, G., de Marco, A., Briani, M., Bocciolone, M., Bragato, R., Corrada, E., Gasparini, G. L., Marconi, M., Monti, L., Pagnotta, P. A., Panico, C., Pini, D., Regazzoli, D., My, I., … Humanitas COVID‐19 Task Force. (2020). Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID‐19. Heart, 106(19), 1512–1518.
Tas, J., van Gassel, R. J. J., Heines, S. J. H., Mulder, M. M. G., Heijnen, N. F. L., Acampo‐de Jong, M. J., Bels, J. L. M., Bennis, F. C., Koelmann, M., Groven, R. V. M., Donkers, M. A., van Rosmalen, F., Hermans, B. J. M., Meex, S. J. R., Mingels, A., Bekers, O., Savelkoul, P., Oude Lashof, A. M. L., Wildberger, J., … van Bussel, B. C. T. (2020). Serial measurements in COVID‐19‐induced acute respiratory disease to unravel heterogeneity of the disease course: Design of the Maastricht Intensive Care COVID cohort (MaastrICCht). BMJ Open, 10(9), e040175.
Twisk, J. W. R. (2023). Applied longitudinal data analysis for medical science: A practical guide (3rd ed.). Cambridge University Press.
van de Berg, T. W., Mulder, M. M. G., Alnima, T., Nagy, M., van Oerle, R., Beckers, E. A. M., Hackeng, T. M., Hulshof, A. M., Sels, J. W. E. M., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & MaastrICCht Collaborators. (2022). Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID‐19 patients: Observations from Maastricht Intensive Care COVID cohort. Frontiers in Cardiovascular Medicine, 9, 9.
van Stipdonk, A. M. W., Ter Horst, I., Kloosterman, M., Engels, E. B., Rienstra, M., Crijns, H., Vos, M. A., van Gelder, I. C., Prinzen, F. W., Meine, M., Maass, A. H., & Vernooy, K. (2018). QRS area is a strong determinant of outcome in cardiac resynchronization therapy. Circulation. Arrhythmia and Electrophysiology, 11(12), e006497.
van Stipdonk, A. M. W., Vanbelle, S., Ter Horst, I. A. H., Luermans, J. G., Meine, M., Maass, A. H., Auricchio, A., Prinzen, F. W., & Vernooy, K. (2019). Large variability in clinical judgement and definitions of left bundle branch block to identify candidates for cardiac resynchronisation therapy. International Journal of Cardiology, 286, 61–65.
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gotzsche, P. C., Vandenbroucke, J. P., & Initiative, S. (2008). The Strengthening the Reporting of Observational STUDIES IN EPIDEMIology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61(4), 344–349.
Wang, Y., Kang, H., Liu, X., & Tong, Z. (2020). Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak. Journal of Medical Virology, 92(6), 538–539.